Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.807
https://www.valueinhealthjournal.com/article/S1098-3015(18)33164-4/fulltext
Title :
Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33164-4&doi=10.1016/j.jval.2018.07.807
First page :
Section Title :
Open access? :
No
Section Order :
44